Titan Medical Inc. (TMDIF)
Market Cap | 16.07M |
Revenue (ttm) | 10.00M |
Net Income (ttm) | -21.04M |
Shares Out | n/a |
EPS (ttm) | -0.18 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 59,286 |
Open | 0.098 |
Previous Close | 0.101 |
Day's Range | 0.096 - 0.110 |
52-Week Range | n/a |
Beta | 3.52 |
Analysts | Buy |
Price Target | n/a |
Earnings Date | n/a |
About TMDIF
Titan Medical Inc., a medical technology company, focuses on the development and commercialization of robotic assisted surgical technologies for application in minimally invasive surgery. It is developing the Enos system, a robotic single access surgical system that includes a surgeon-controlled patient cart comprising a 3D high-definition vision system and multi-articulating instruments for performing surgical procedures; and a surgeon workstation that provides the surgeon with ergonomic interface to the patient cart and a 3D endoscopic view i... [Read more]
Financial Performance
In 2021, Titan Medical's revenue was $20.09 million, an increase of 0.47% compared to the previous year's $20.00 million. Losses were -$14.86 million, -38.56% less than in 2020.
Financial StatementsNews

Titan Medical Announces Delays in its Annual Filings and Planned Deregistration with the SEC
TORONTO, ON, March 22, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD; OTC: TMDIF) today announces that, as a result of certain financial and operational challenges t...

Titan Medical Announces Decision of Nasdaq Hearings Panel to Delist Common Shares
Common shares to continue to trade on the Toronto Stock Exchange and are expected to trade on the OTC Markets Common shares to continue to trade on the Toronto Stock Exchange and are expected to trade...

Titan Medical Announces Executive Leadership Updates and Receipt of Nasdaq Notification Regarding Audit Committee Requirements
Toronto, Ontario, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (the “Company” or “Titan”) (Nasdaq: TMDI; TSX: TMD) today announced senior leadership changes and the receipt of a notification f...

Titan Medical Provides Corporate Update
Announces Further Costing Reduction Activities and Updates to Strategic Review Process Announces Further Costing Reduction Activities and Updates to Strategic Review Process

Titan Medical Shares Latest Technology Innovation and Announces Meeting Participation During J.P. Morgan Healthcare Conference Week
TORONTO, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies fo...

Titan Medical Announces Receipt of Nasdaq Listing Determination; Company to Request Hearing
TORONTO, ON, Dec. 28, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD) (the “Company”), a medical device company focused on the development and commercialization of innovative surg...

Titan Medical Granted Patent Covering User Experience, Further Enhancing its Intellectual Property in Robotic Assisted Surgery
TORONTO, ON, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologie...

Titan Medical Suspends Special Meeting of Shareholders in Conjunction with Initiation of Strategic Review Process
TORONTO, Dec. 07, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on single access robotic-assisted surgery (RAS), today announced that in vi...

Titan Medical Implements Cost-Cutting Measures to Support Strategic Review Process
TORONTO, ON, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on single access robotic-assisted surgery (RAS) system, today announced...

Titan Medical Announces Commencement of Strategic Review Process
TORONTO, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD) (“Titan” or the “Company”), a medical technology company focused on single access robotic-assisted surgery (RAS),...

Titan Medical Announces American Association of Gynecologic Laparoscopy Global Congress Participation
TORONTO, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on single access robotic-assisted surgery (RAS), today announced its attend...

Titan Medical Reports Financial Results for the Third Quarter 2022, and Announces Special Shareholder Meeting
Shareholder Meeting to Support Share Consolidation to Maintain Nasdaq Listing Shareholder Meeting to Support Share Consolidation to Maintain Nasdaq Listing

Titan Medical to Issue Third Quarter 2022 Financial Results on November 10, 2022
Webcast to Follow Announcement Webcast to Follow Announcement

Titan Medical Announces Appointment of Eric Heinz as Vice President, Market and Corporate Development
TORONTO, ON, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologi...

Titan Medical Announces Publication of Patent Application Expanding Commitment to Continued Innovation in Single Access Robotic Assisted Surgery
Strengthens company's intellectual property portfolio with innovations in next generation single access RAS technology Strengthens company's intellectual property portfolio with innovations in next ge...

Titan Medical Signs Definitive Agreement with Medtronic
Titan to support Medtronic development and pre-clinical activities through supply of instruments and cameras Titan to support Medtronic development and pre-clinical activities through supply of instru...

Titan Medical to Present at the H.C. Wainwright Global Investment Conference
TORONTO, Sept. 06, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical technology company focused on single access robotic-assisted surgery (RAS) system, today announced th...

Titan Medical Reports Financial Results for the Second Quarter 2022
New CEO Appointed, Manufacturing Progress Noted New CEO Appointed, Manufacturing Progress Noted

Titan Medical to Issue Second Quarter 2022 Financial Results on August 11, 2022
Webcast to Follow Announcement Webcast to Follow Announcement

Titan Medical Announces Appointment of Cary G. Vance as President and Chief Executive Officer
TORONTO, June 30, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies fo...

Titan Medical Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Rule
TORONTO, June 29, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies fo...

Titan Medical Provides Update to Enos Project Timeline
De Novo marketing authorization planned for early 2025 remains unchanged De Novo marketing authorization planned for early 2025 remains unchanged

Titan Medical to Participate at the Society of Robotic Surgery Annual Meeting
TORONTO, June 23, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies fo...

Titan Medical Announces Agreement with Nissha Medical Technologies
TORONTO, ON, June 21, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologie...

Titan Medical Reports Voting Results From Annual and Special Meeting of Shareholders
TORONTO, June 09, 2022 (GLOBE NEWSWIRE) -- Titan Medical Inc. (Nasdaq: TMDI; TSX: TMD), a medical device company focused on the development and commercialization of innovative surgical technologies fo...